Arnold Lauren D, Patel Alpa V, Yan Yan, Jacobs Eric J, Thun Michael J, Calle Eugenia E, Colditz Graham A
Department of Surgery, Washington University in St. Louis, St. Louis, MO 63100, USA.
Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2397-405. doi: 10.1158/1055-9965.EPI-09-0080. Epub 2009 Sep 1.
Between 2001 and 2005, Blacks from the United States experienced a 32% higher pancreatic cancer death rate than Whites. Smoking, diabetes, and family history might explain some of this disparity, but prospective analyses are warranted. From 1984 to 2004, there were 6,243 pancreatic cancer deaths among Blacks (n = 48,525) and Whites (n = 1,011,864) in the Cancer Prevention Study II cohort. Multivariate Cox proportional hazards models yielded hazards ratios (HR) for known and suspected risk factors. Population attributable risks were computed and their effect on age-standardized mortality rates were evaluated. Blacks in this cohort had a 42% increased risk of pancreatic cancer mortality compared with Whites (HR, 1.42; 95% confidence intervals (CI), 1.28-1.58). Current smoking increased risk by >60% in both races; although Blacks smoked less intensely, risks were similar to Whites (HR(Black), 1.67; 95% CI, 1.28-2.18; HR(White), 1.82; 95% CI, 1.7-1.95). Obesity was significantly associated with pancreatic cancer mortality in Black men (HR, 1.66; 95% CI, 1.05-2.63), White men (HR, 1.42; 95% CI, 1.25-1.60), and White women (HR, 1.37; 95% CI, 1.22-1.54); results were null in Black women. The population attributable risk due to smoking, family history, diabetes, cholecystectomy, and overweight/obesity was 24.3% in Whites and 21.8% in Blacks. Smoking and overweight/obesity play a substantial a role in pancreatic cancer. Variation in the effect of these factors underscores the need to evaluate disease on the race-sex level. The inability to attribute excess disease in Blacks to currently known risk factors, even when combined with suspected risks, points to yet undetermined factors that play a role in the disease process.
2001年至2005年期间,美国黑人的胰腺癌死亡率比白人高32%。吸烟、糖尿病和家族病史可能是造成这种差异的部分原因,但仍需进行前瞻性分析。在癌症预防研究II队列中,1984年至2004年期间,黑人(n = 48,525)和白人(n = 1,011,864)中有6243人死于胰腺癌。多变量Cox比例风险模型得出了已知和可疑风险因素的风险比(HR)。计算了人群归因风险,并评估了它们对年龄标准化死亡率的影响。该队列中的黑人患胰腺癌死亡的风险比白人高42%(HR,1.42;95%置信区间(CI),1.28 - 1.58)。当前吸烟使两个种族的风险增加了60%以上;尽管黑人吸烟强度较低,但其风险与白人相似(HR(黑人),1.67;95% CI,1.28 - 2.18;HR(白人),1.82;95% CI,1.7 - 1.95)。肥胖与黑人男性(HR,1.66;95% CI,1.05 - 2.63)、白人男性(HR,1.42;95% CI,1.25 - 1.60)和白人女性(HR,1.37;95% CI,1.22 - 1.54)的胰腺癌死亡率显著相关;黑人女性的结果为阴性。吸烟、家族病史、糖尿病、胆囊切除术和超重/肥胖导致的人群归因风险在白人中为24.3%,在黑人中为21.8%。吸烟和超重/肥胖在胰腺癌中起重要作用。这些因素影响的差异凸显了在种族 - 性别层面评估疾病的必要性。即使将已知风险因素与可疑风险因素结合起来,也无法将黑人中过多的疾病归因于这些因素,这表明在疾病过程中还有尚未确定的因素在起作用。